Lin Tai-An 4
4 · SpringWorks Therapeutics, Inc. · Filed Jan 8, 2024
Insider Transaction Report
Form 4
Lin Tai-An
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-04+15,000→ 15,000 totalExercise: $38.40Exp: 2034-01-03→ Common Stock (15,000 underlying) - Award
Common Stock
2024-01-04+5,289→ 29,289 total
Footnotes (2)
- [F1]This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty-three percent (33%) to vest on January 4, 2025, another thirty-three percent (33%) to vest on January 4, 2026 and the remaining thirty-four percent (34%) to vest on January 4, 2027, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.
- [F2]This option shall vest in forty-eight (48) equal monthly installments following January 4, 2024, subject to continued service to the Issuer by the Reporting Person through each applicable vesting date.